Hoffer-SchaeferA, RozyckiHJ, YoppMA, RubinBK. Guaifenesin has no effect on sputum volume or sputum properties in adolescents and adults with acute respiratory tract infections. Respiratory Care, 2014; 59(5):631-636.
2.
VoynowJA, RubinBK. Mucins, mucus, and sputum. Chest, 2009; 135(2):505-512.
3.
KesimerM, MakhovAM, GriffithJD, VerdugoP, SheehanJK. Unpacking a gel-forming mucin: a view of MUC5B organization after granular release. Am J Physiol Lung Cell Mol Physiol, 2010; 298(1):L15-L22.
4.
RogersDF. Mucoactive agents for airway mucus hypersecretory diseases. Respir Care, 2007:52(9):1176-1193; discussion 1193-1197.
5.
O'ConnellOJ, O'FarrellC, HarrisonMJ, EustaceJA, HenryMT, PlantBJ. Nebulized hypertonic saline via positive expiratory pressure versus via jet nebulizer in patients with severe cystic fibrosis. Respir Care, 2011; 56(6):771-775.
6.
SmithSM, SchroederK, FaheyT. Over-the-counter (OTC) medications for acute cough in children and adults in ambulatory settings. Cochrane Database Syst Rev. 2012;(1):CD001831.
AlbrechtH, VernonM, SolomonG. Patient-reported outcomes to assess the efficacy of extended-release guaifenesin for the treatment of acute respiratory tract infection symptoms. Respir Res, 2012; 13:118.
